bioFAST-AI

bioFAST-AI

Supervised machine learning approach for Flow Cytometry AST (FAST)

Sepsis, an often fatal condition, requires immediate antibiotic prescription regardless of the infectious agent. Finding the most effective antibiotic requires an Antimicrobial Susceptibility Test (AST) which usually takes two days before results are available. During this time the patient is treated with broad spectrum antibiotics, with severe consequences for their long term effectiveness.

FASTinov, with support from μRoboptics, has developed a rapid-AST directly from the infected patient’s blood that delivers results in under two hours.

In this novel project, FASTinov and μRoboptics will use supervised machine learning techniques to create a classification model from flow cytometry data in a real clinical setting at Hospital Ramon et Cajal, Madrid.

Partners:

  • FASTinov S.A. (Portugal)

FASTinov Website:

http://fastinov.com

Disclaimer: The content of this document represents the view of the author only and is his/her sole responsibility: it cannot be considered to reflect the views of the European Commission and/or the Executive Agency for Small and medium-size Enterprises (EASME). The European Commission and the Agency do not accept responsibility for the use that may be made of the information it contains.